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Abstract
Background: It is important to establish whether or not the presence of malaria parasites in
peripheral blood of asymptomatic individuals is a predictor of future clinical mild malaria attacks
(MMA). The aim of this study was to determine how an asymptomatic positive thick blood smear
could be related to the occurrence of a MMA during the nine following days.
Methods: The study was conducted in a cohort of 569 Senegalese children, who were investigated
for Plasmodium falciparum asymptomatic carriage at two different times of the transmission season,
the beginning (September) and the end (November). The occurrence of MMA was investigated in
asymptomatic carriers and non-carriers, every three days for nine consecutive days. Survival
analysis was performed and risk estimates were calculated by Cox proportional hazards model.
Results: At the beginning of the transmission season, 27.8% (147/529) of the children were
asymptomatic carriers (ACs) and 5.4% (8/147) of MMA occurred among these, versus 1% (4/382)
among non-carriers (RR = 5.32; IC = [1.56–18.15], p = 0.008). At the end of the transmission
season, the frequency of asymptomatic carriers was similar to that observed at the beginning of the
season (31.9%, p = 0.15), but no MMA was detected during this period.
Conclusion:  A significant association between P. falciparum asymptomatic carriage and the
occurrence of MMA at the beginning of the transmission season was demonstrated, with a five-fold
increase in the risk of developing a MMA in ACs. In the context of a possible distribution of IPTc
in the future, drug strategies may have dramatic consequences due to the existence of ACs (both
long term and short term), as they seem to play an important role in the individual protection to
malaria, in the most exposed age groups.
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Background
Plasmodium falciparum asymptomatic carriers (ACs), i.e.,
individuals harbouring parasites without clinical signs,
are numerous in areas of high transmission. The conse-
quences and significance of such asymptomatic infections
have both been studied in diverse situations and from
complementary approaches, but these studies led to con-
tradictory results [1-4]. According to a few authors, long
term asymptomatic carriage may represent a form of tol-
erance to the parasite in children building up their
immune response. In this way, asymptomatic carriage
would protect these children from developing either a
mild malaria attack (MMA) or a more severe one, by keep-
ing their immunity effective [1-3]. Conversely, asympto-
matic carriage may represent a mode of entry to
symptomatic malaria, especially in young children [4,5].
It is important to understand the process which leads
some of these children to suddenly develop a MMA. The
time course of the relation between Plasmodium falciparum
infection and MMA occurrence needed to be investigated
[5]. If the clinical outcome of infection can be determined
by the host's ability to regulate the parasite growth over
time, the way by which this regulation prevents the dis-
ease is incompletely known [3,6,7]. Investigating this
issue other important factors have to be considered, such
as the age of exposed children, or the multiplicity of infec-
tions by different plasmodial populations in a single indi-
vidual [1-4].
Treatment of asymptomatic individuals, regardless of
their malaria infection status, with regularly spaced thera-
peutic doses of antimalarial drugs has been proposed as a
method to reduce malaria morbidity and mortality [8].
This strategy, called intermittent preventive treatment
(IPT), is currently employed for pregnant women (IPTp)
and is being studied for infants (IPTi) and children (IPTc).
The effects of repeated treatments on the development of
immunity are the major challenges of intermittent preven-
tive treatment [9] and it is of great importance to increase
the knowledge on the asymptomatic carriage of malaria
parasites in order to help to assess the risk/benefit ratio of
such new strategies.
To evaluate how asymptomatic carriage could be related
to the occurrence of uncomplicated malaria attacks, a fol-
low-up of a cohort of Senegalese children was carried on
in an area of marked seasonal transmission. To determine
the variations of the balance between clinical signs and
the absence of symptoms during the transmission season,
a survey on the same population at the beginning and at
the end of the transmission season was performed (i.e.
September and November 2002).
Methods
Study sites
This study was carried out during the 2002 malaria trans-
mission season, in two villages of the Niakhar area (Dio-
hine and Toucar), located 150 km south-east of Dakar
[10]. The climate is characteristic of a sahelian region with
distinct rainy (from July to September) and dry seasons
(October to June). Malaria transmission is seasonal, from
the middle of August until the end of November, with a
peak in September. Transmission has been estimated
between nine and 12 infective bites per person and per
year, exclusively by mosquitoes of the Anopheles gambiae
s.l. complex, mainly by Anopheles arabiensis [10,11]. Plu-
viometric data collected by an IRD team in 2002 showed
that the two villages were equivalent in terms of numbers
of rainy days (5/14 days) and of quantity of water fallen
(6.12 mm at Diohine and 5.19 mm in Toucar, p = 0.80)
during the two weeks preceding the study.
Population study and study design
566 children and adolescents, from two to 17 years of age,
were investigated twice during the study: at the beginning
(September 2002) and at the end (November 2002) of the
transmission season. All eligible children in the area were
asked, at each period, to attend the health centre where a
systematic thick blood smear was performed. A urine sam-
ple was collected in order to check for the presence of
chloroquine metabolites. Children were classified accord-
ing to their clinical and parasitological status: (1) children
harbouring a P. falciparum parasitaemia without fever or
clinical signs were classified as asymptomatic carriers
(ACs); (2) children with a negative thick blood smear
were classified as non-carriers, and (3) children presenting
with a clinical malaria attack (see below) were treated and
further excluded from the analysis.
An active survey of clinical malaria attacks was set up.
Children were visited at home every three days by investi-
gators recording axillary temperature. In case of tempera-
ture exceeding 37.5°C or fever reported by the parents
since the last visit (or other symptoms such as headache,
vomiting and weakness), a thick blood smear was per-
formed. Parents were urged to bring their child to the
health centre between the scheduled visits if any kind of
symptom appeared. A MMA was defined as the associa-
tion of a temperature over 37.5°C (or reported fever
between two visits) and a parasite density over 2,500 tro-
phozoites/μl of blood. The same threshold had been pre-
viously used in various studies performed among
populations living in the Niakhar area [12-14]. At each
transmission period, we performed this three-day peri-
odic control of clinical malaria attacks for a whole dura-
tion of the nine days following the date of the systematic
thick blood smear. A nine days follow-up was undertaken,
which is the time period corresponding to approximatelyMalaria Journal 2008, 7:193 http://www.malariajournal.com/content/7/1/193
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four life cycles of P. falciparum, in order to minimize the
probability to deal with reinfections [15].
When a clinical malaria attack was suspected, a presump-
tive treatment was administered according to the "Pro-
gramme National de Lutte contre le Paludisme" (PNLP)
recommendations. This protocol was approved by the
ethics committee of the Health Ministry of the Republic of
Senegal (N°000526/MS/DERF/DER).
Laboratory methods
Plasmodium falciparum asexual blood forms were counted
on Giemsa-stained smears, using a previously described
method [13]. A blood smear was declared negative when
no parasite was detected in 200 fields. The presence of
chloroquine in urine samples was assessed by a colorimet-
ric method (Haskins modified by Mount, HMM II), and
positive results (≥ 3 μg/ml) gave information about previ-
ous intake of antimalarial drugs [16].
Measured covariates
For each child the following covariates were collected: (1)
sex; (2) age; (3) village of residence and (4) presence of
chloroquine metabolites in urine (≥ 3 μg/ml).
Statistical procedure
The same statistical strategy was applied during the two
periods. We first performed an univariate analysis to test
for associations between the occurrence of MMA (yes/no),
asymptomatic carriage (yes/no), and measured covariates.
Pearson's chi-square and one-way analysis of variance
were used for qualitative and quantitative variables
respectively. When non parametric methods were
required, Fisher's exact test or Kruskall-Wallis test were
applied. Factors associated with asymptomatic carriage
and MMA occurrence were selected at a p value < 0.15.
The delay between the systematic parasitological measure-
ment and the appearance (or not) of a MMA during the
nine following days was analysed, using survival time data
procedures.
- The Kaplan-Meier survival analysis and the Log-Rank test
were used to compare incidence rates of MMA between
ACs and non-carriers.
- The Cox proportional hazards model was used to analyse
the time to development of a MMA in each group,
adjusted on the covariates found significant (p < 0.15) in
the univariate analysis.
Survival times were estimated as follows (Figure 1): the
baseline (time 0) was defined as the date of enrolment
(date of systematic thick blood smear); the time to first
MMA was defined as the interval between the baseline
date and the MMA occurrence date. Subjects who pre-
sented no MMA during the follow-up were censored at the
endpoint, at Day 9. Proportional Hazard (PH) and log-
linearity hypotheses were tested. For all analyses, a p value
below 0.05 was considered significant. The statistical anal-
yses were performed using Stata v. 6.0.
Results
Study population
A total of 529 and 527 children from the original 566
were enrolled respectively at the beginning and at the end
of the transmission season. The mean age (SD) of the pop-
ulation was 8.6 (0.15) years and the sex-ratio (male/
female) was 1.35. Fifty seven per cent of children
belonged to the village of Diohine and forty three percent
to the village of Toucar. Children who did not attend the
health centre in September (n = 37) and in November (n
= 39) were significantly older than children who did.
Activities such as farm work or looking after livestock may
explain this difference.
Beginning of the transmission season
In September, 27.8% (147/529) of the children were
asymptomatic carriers (Figure 1). The mean parasite den-
sity was 7,169.4 parasites/μl of blood (SD = 34943.8). No
differences on mean parasite density according to the day
of enrolment were observed (p = 0.73). Plasmodial index
varied from one day to another (p < 10-3), bur without any
particular trend of increase. The proportion of AC did not
differ (p > 0.70) between children with CQ metabolites in
their urine (9/36; 25%) and others (129/468; 27.6%). No
child was lost to follow-up. During the nine following
days, 2.3% (12/529) of the whole group presented a
MMA, i.e. 5.4% (8/147) of the ACs and 1.0% (4/382) of
the non carriers. The mean parasite density was 34,243.3
parasites/μl of blood (SD = 31,460.6), extremes values
going from 4,040 to 108,800 parasites/μl of blood. The
information concerning the use of impregnated bednets
was collected. It appears that 7.52% of asymptomatic car-
riers reported the use of these bednets, vs 5.38% among
non carriers, p = 0.624. All children who presented a mild
malaria attack were not sleeping under impregnated bed-
nets (unknown data for 2 children in this group). Infor-
mation concerning the treatment delivered in the area by
the dispensaries during the study was collected by our
team and we didn't notice differences among villages.
Association between asymptomatic carriage and MMA 
occurrence
Associations between MMA, asymptomatic carriage, and
measured covariates (age, sex, village and chloroquine in
urine) in univariate analysis are shown in Table 1. There
was a significant association (p = 0.005) between P. falci-
parum asymptomatic carriage at inclusion and the occur-
rence of a MMA during the nine following days. Village ofMalaria Journal 2008, 7:193 http://www.malariajournal.com/content/7/1/193
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residence (p < 0.0001) and, in a lesser extent, sex (p =
0.06) were associated with asymptomatic carriage. Age
was neither associated with MMA nor asymptomatic car-
riage. However because of its importance, it was included
in multivariate analysis as well.
Survival analysis
The rate of MMA occurrence was significantly higher over
the nine days of follow-up in ACs compared to non carri-
ers (6.8% vs. 1.6%, p = 0.002) (Figure 2).
Multivariate analysis (Cox model)
Plasmodium falciparum asymptomatic carriage was predic-
tive of a MMA occurrence during the nine following days.
Plasmodium falciparum ACs had a five-fold increased risk of
MMA compared to non carriers (RR = 5.32, IC = [1.56–
18.16], p = 0.008) (Table 2). Age, sex and village did not
remain significant after adjustment. The proportional
hazard assumption was respected according to global and
graphical tests.
End of the transmission season
527 children out of 566 were present at the end of the
malaria transmission season (Figure 3). Three children
presented a MMA on the day of enrolment and were
excluded. The remaining 524 children did not differ from
those included in the first study period for age, sex ratio,
village of residence and frequency of positiveness for the
Clinical malaria occurrences over time at the beginning of the malaria transmission season, Niakhar, 2002 Figure 1
Clinical malaria occurrences over time at the beginning of the malaria transmission season, Niakhar, 2002. § n: 
number of patients per day. # PI: Plasmodial Index (= ACs frequency).Malaria Journal 2008, 7:193 http://www.malariajournal.com/content/7/1/193
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search of chloroquine metabolites in the urine. The mean
parasite density at enrolment was 5,597.6 parasites/μl (SD
= 13,941.1) and was not different from the beginning of
the transmission season (p = 0.14). The frequency of Plas-
modium falciparum ACs was similar at enrolment between
the two periods (27.8% at the beginning vs. 31.9% at the
end of the transmission season, p = 0.15). The parasite
density was homogenous during the 10 days of enrolment
(p = 0.13), but not the plasmodial index (p = 0.005), even
if there was no particular trend of increase. The same pat-
tern of results concerning the association of AC and meas-
ured covariates as observed in September, was observed at
this period. No MMA occurred during the nine following
days.
Discussion
This study demonstrated that, in a cohort of Senegalese
children, there was a significant association between P.
falciparum asymptomatic carriage and the occurrence of
MMA. The relation was true at the beginning (September),
but not at the end of the transmission season (Novem-
ber). In the first period, children harbouring P. falciparum
had a five-fold increased risk to develop a MMA during the
nine following days, independently of their age.
Plasmodium falciparum asymptomatic carriage concerns a
very important proportion of exposed populations in
endemic areas. However, the accurate definition of
asymptomatic carriage relative to its duration (i.e. long
term or short term) differs from one study to another. In
the present work it was intended to minimize the proba-
bility to deal with reinfections and a short term follow-up
of nine days was chosen, as done by Bouvier et al in a pre-
vious study [15]. The definition of a case of malaria is also
important. Bouvier, whose protocol was a close follow-up
including daily fever survey, showed in Mali an associa-
tion between AC and the occurrence of fever during the
nine following days, which depended on both season and
age [15].
To see if there was a similarity with the results of Bouvier,
the survival analysis was performed using different diag-
nosis criteria for MMA (temperature over 37.5°C associ-
ated with a positive blood smear regardless of parasite
density). The main results of the study were confirmed
with these different criteria, both at the beginning and at
the end of the transmission season.
The results of the present study show the absence of effect
of age on children susceptibility to present a MMA, which
is an important individual parameter concerning the
acquisition of immunity. They differ from a recent study
performed in Tanzania, which evidenced an age-depend-
ent risk of clinical malaria associated with asymptomatic
carriage [4]. In this latter study, at the beginning of the fol-
low-up, parasitaemic children below one year of age had
a three-fold increase in clinical malaria incidence, com-
pared to aparasitaemic children of the same age. In older
children, baseline parasitaemia appeared to be a protec-
tive factor. The authors suggested that repeated P. falci-
parum infections induced a protective response in older
children regularly exposed with less subsequent morbid-
ity. Conversely, in young children with low previous
exposure, recent malaria infection represented a higher
risk of clinical attacks [17,18].
Table 1: Association between P. falciparum asymptomatic carriage or clinical malaria occurrence and other covariates at the beginning 
of the malaria transmission season, Niakhar, 2002.
MMA P. falciparum asymptomatic carriage
Number (%) p value* Number (%) P value Total Number
P. falciparum asymptomatic carriage
Yes 8 5,4 0,005 147
No 4 1,0 382
Age (years)
[2–5] 3 2,6 0,93 29 25,4 0,56 114
[6–10] 5 2,1 64 26,8 239
[11–17] 4 2,3 54 30,7 176
Sex
M 7 2,3 0,95 94 30,9 0,06 304
F 5 2,2 53 23,6 225
Village
Diohine 5 1,7 0,34 63 21,5 < 0,001 292
Toucar 7 2,9 84 35,4 237
Chloroquine in urine a
Yes 0 0 - 9 25 0,74 36
No 12 2,6 129 27,6 468
a Data available for 504 childrenMalaria Journal 2008, 7:193 http://www.malariajournal.com/content/7/1/193
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Differences in the levels of malaria transmission between
the two study areas (Tanzania and Senegal) can be an
explanation to the observed discrepancies. Transmission
is intense and perennial in Tanzania, while in Niakhar it
is low and strongly seasonal. Moreover, in the study
period (2002), the overall rainfall level in Niakhar was
notably lower than the mean rainfall over the past 16
years (1984–2000) [11]. It can thus be considered that
children from Niakhar were less exposed to infection and
hence, their susceptibility to malaria was maintained,
contrary to Tanzanian children who probably had
acquired an earlier protective immunity.
Differences observed between the beginning and the end
of transmission season could be explained by the hypoth-
esis that immunity to uncomplicated malaria symptoms,
which requires an important number of infections over
many years to become established, can be partitioned in
two components: an immunity refraining the outbreak of
symptoms (clinical immunity) and an immunity allowing
MMA rate estimates in ACs and non carriers by the Kaplan Meier method at the beginning of the malaria transmission season,  Niakhar, 2002 Figure 2
MMA rate estimates in ACs and non carriers by the Kaplan Meier method at the beginning of the malaria 
transmission season, Niakhar, 2002.
Kaplan-Meier survival estimates, by carriage 
  
analysis time







Table 2: Cox multivariate analysis: time to first MMA in relation 
with P. falciparum asymptomatic carriage and other covariates at 
the beginning of the malaria transmission season, Niakhar, 2002.
RR (95% CI) P value
Asymptomatic carriage
Noa 1
Yes 5.32 [1.56–18.16] 0.008
Age
[2–5]a 1
[6–10] 0.76 [0.18–3.18] 0.704
[11–17] 0.82 [0.18–3.71] 0.798
Gender
Fa 1
M 0.84 [0.26–2.74] 0.778
Village
Diohinea 1
Toucar 0.58 [0.04–8.28] 0.690
a Reference classMalaria Journal 2008, 7:193 http://www.malariajournal.com/content/7/1/193
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to control parasite density (infection immunity)
(reviewed in [19]). The ability to control symptoms devel-
ops before the ability to control parasite replication, as
suggested by the rate of parasite density required for the
symptoms to appear [20-22]. However, immune mecha-
nisms allowing the control of parasite growth may remain
active in the absence of re-infections during the dry season
(from January to September), contrary to clinical immu-
nity, which could be quickly lost in the absence of stimu-
lation [19]. The results of the present study could be
explained by a rapid loss of the immune mechanisms
involved in clinical immunity during the nine month-
long dry season in the absence of re-infection. Conse-
quently, children infected early at the beginning of the
transmission season in September presented an increased
risk to develop rapidly a MMA. Then, after repeated infec-
tions, the majority of them possibly recovered an effica-
cious clinical immunity, explaining the absence of MMA
in November.
Moreover, the multiplicity of infections (MOI) by differ-
ent plasmodial strains can bring a complementary expla-
nation to the differences found in the study between the
beginning and the end of the transmission season. The
role of MOI on malaria morbidity has recently drawn a lot
of attention but several contradictory results have been
published. Mayor et al have shown that multiple infec-
tions are associated with an increased number of clinical
episodes in very low transmission areas [23]. Conversely,
several studies on partially immune children have found
opposite results in areas of high [1,3] as well as low-to-
moderate but perennial transmission [2]. In the Senega-
lese area, the characterization of parasites, based on msp2
genotyping, was performed in June 2002 (before the
Clinical malaria occurrences over time at the end of the malaria transmission season, Niakhar, 2002 Figure 3
Clinical malaria occurrences over time at the end of the malaria transmission season, Niakhar, 2002. § n: 
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transmission season) and January 2003 (at the end of the
transmission season) in a cohort of 400 children living in
the same villages as the children enrolled in the present
study. A significant increase of the mean value of MOI was
found between June 2002 and January 2003, i.e. 2.5 and
4.1 respectively (p < 10-4) [24]. These results are consistent
with the idea that the emergence of new Plasmodium falci-
parum genotypes during the transmission peak in Septem-
ber can be associated with an increased incidence of
MMA. Later in the transmission season, children may
have recovered their clinical immunity quickly as they
have been accumulating infections by various parasite
strains.
Treatment of asymptomatic individuals with regularly
spaced therapeutic doses of antimalarial drugs, called IPT,
has been proposed as a method to reduce malaria morbid-
ity and mortality. At the same period and in the same area,
a clinical trial was undertaken by Cisse et al to determine
the efficacy of IPTc to protect children from presenting a
MMA. IPTc was distributed to children from two to 59
months living in villages surrounding the two villages of
the present study, at three periods of the transmission sea-
son. Doses where delivered in September (beginning of
the transmission season), October (four weeks after the
first dose) and November (end of the transmission sea-
son) and they obtained high degrees of protection against
clinical malaria, with a 90% decrease in MMA incidence
[25]. Such high levels of protection were not confirmed by
other studies realised in Mali [26] or Ghana [27].
The results of the present study lead to interrogations. In
the case of a systematic distribution of IPTc by health
workers at the beginning of the transmission season, all
children would be treated independently of their parasite
carriage, i.e. children at risk at the beginning and pro-
tected at the end of the transmission season (ACs) as well
as non carriers, protected at the end of the season. Immu-
nological protection against malaria would be somehow
replaced by chemical protection. The consequence of an
interruption of IPT distribution, due to low availability of
the drugs or dysfunction of the distribution process would
be an incomplete coverage of chemical protection during
the transmission season. Supposing the second dose,
given in October, was not distributed, the situation would
be similar to the beginning of the transmission season as
described in the present study. Children could present a
MMA at the end of the transmission season, with no
noticeable benefit due to IPT.
A recently published study on the same population has
focused on long term asymptomatic carriage [28]. ACs
were detected in June 2002 and it was demonstrated that
asymptomatic carriage during the dry season was a protec-
tive factor against MMA during the next transmission sea-
son. These results were confirmed in the following year
and among the long term ACs defined in 2002, 90 chil-
dren were also found to be ACs in 2003. These very partic-
ular children were denoted as potentially protected. ACs
who presented a MMA in the present study were not
belonging to this group of 90 long term ACs, suggesting
the existence of two different types of ACs: short term
exposed to clinical malaria and long term presumably
protected.
The long term P. falciparum carriage would be suppressed,
as well as short term carriage, in the event of IPT distribu-
tion. Thus, the consequences of a shortage of drugs would
be dramatic, as potentially increasing the population of
susceptible children. The existence of ACs, both short
term and long term, stresses the atmost importance of a
perfect coverage of the transmission season by IPT, with
sufficient drug supplies and well motivated health work-
ers, as explained by Greenwood [29].
Conclusion
In a seasonal marked malaria transmission area, asympto-
matic carriers are at risk of presenting a MMA at the begin-
ning of the transmission season, and not at the end. Such
differences observed between the two periods within the
transmission season can be related both to the acquisition
of immunity and the evolution of the genetic diversity of
parasite strains in the course of the transmission season.
In the future, it may be important to assess epidemiologi-
cal or interventional studies in transmission area, taking
into account the period within the transmission season.
The interest on asymptomatic carriage should not be
abandoned, as it may be a form of protection at some
moments of the year. The probable existence of several
types of asymptomatic carriage (i.e. short term and long
term) and their characteristics have to continue to be
investigated, at the time when intermittent preventive
treatment for infants (IPTi) and children (IPTc) is under
evaluation and could be applied generally.
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